Pricing Log in Create free account

ANIXA BIOSCIENCES INC (ANIX) vs Outlook Therapeutics, Inc. (OTLK)

ANIXA BIOSCIENCES INC and Outlook Therapeutics, Inc. are both Biotechnology companies. ANIXA BIOSCIENCES INC and Outlook Therapeutics, Inc. are of similar size ($106.9M and $105.3M). ANIXA BIOSCIENCES INC grew revenue faster over the last twelve months: −34.1% against −113.6%. Outlook Therapeutics, Inc. has the higher net margin (5,253.4% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Outlook Therapeutics, Inc. leads on 9 and ANIXA BIOSCIENCES INC on 6.

Valuation

Metric ANIX OTLK Biotechnology median
P/E n/m n/m 10.60
P/S 111.13 n/m 9.40
P/B 8.18 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 100.73 (66.10) 9.02
Earnings yield (10.13%) (200.49%) (32.88%)
Free cash flow yield (6.80%) (96.25%) (23.13%)

Profitability

Metric ANIX OTLK Biotechnology median
Gross margin 0.00% 195.62% 68.51%
Operating margin 0.00% 4,781.76% 0.00%
Net margin 0.00% 5,253.40% 0.00%
Free cash flow margin 0.00% 4,826.38% 0.00%
Return on equity (72.57%) 256.92% (51.96%)
Return on assets (63.45%) (251.66%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANIX OTLK Biotechnology median
Revenue growth (TTM) (34.10%) (113.55%) 6.76%
EPS growth (last fiscal year) 12.82% 55.81% 29.88%
Revenue growth, 5-year CAGR (6.89%) (22.99%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANIX OTLK Biotechnology median
Debt to equity 0.00 (1.75) 0.00
Current ratio 8.55 0.81 4.97
Net debt to EBITDA 1.29 (0.33) 1.01

Dividend

Metric ANIX OTLK Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ANIX OTLK Biotechnology median
Market cap 105.34m 106.90m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack